ANTI-OXIDIZED LDL ANTIBODIES AND ANTIPHOSPHOLIPID ANTIBODIES IN HEALTHY-SUBJECTS - RELATIONSHIP WITH LIPOPROTEIN-RELATED AND OXIDATION-RELATED ANALYTES

被引:18
作者
CRAIG, WY
POULIN, SE
NEVEUX, LM
PALOMAKI, GE
DOSTALJOHNSON, DA
LEDUE, TB
RITCHIE, RF
机构
[1] Foundation for Blood Research, Scarborough
关键词
D O I
10.1006/jaut.1995.0053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IgG autoantibodies against malondialdehyde-modified LDL (alpha oxLDL), antiphospholipid antibodies (APA) and oxidation- and lipoprotein-related analytes were assayed in sera from healthy subjects (51 males, 115 females, aged 22-63 years). alpha OxLDL levels were associated (P<0.03) with IgG alpha cardiolipin (r=0.18), IgM alpha cardiolipin (r=0.17) and IgM alpha phosphatidylserine (r=0.16) but not with age, cholesterol, triglyceride, apolipoproteins B and AI, lipoprotein(a), lipid peroxides, ceruloplasmin, copper, ferritin, transferrin or iron. APA levels were inversely associated with levels of both oxidation- and lipoprotein-related analytes. Ferritin (3.5%) and alpha oxLDL (1.4%) contributed independently to variation in IgG alpha cardiolipin levels, and apo B (2%) to variation in IgM alpha cardiolipin levels. These associations are small, indicating that there are no major biological associations between the measured variables. The lack of association between alpha oxLDL and lipoprotein- or oxidation-related analytes suggests that the relevant antigen is not in serum. (C) 1995 Academic Press Limited
引用
收藏
页码:713 / 726
页数:14
相关论文
共 46 条
[31]  
MARCOVINA SM, 1993, CLIN CHEM, V39, P773
[32]   ANTIPHOSPHOLIPID ANTIBODIES ARE DIRECTED AGAINST A COMPLEX ANTIGEN THAT INCLUDES A LIPID-BINDING INHIBITOR OF COAGULATION - BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) [J].
MCNEIL, HP ;
SIMPSON, RJ ;
CHESTERMAN, CN ;
KRILIS, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4120-4124
[33]  
OREKOV A, 1990, ARTERIOSCLER THROMB, V11, P316
[34]   LOW-DENSITY LIPOPROTEIN UNDERGOES OXIDATIVE MODIFICATION INVIVO [J].
PALINSKI, W ;
ROSENFELD, ME ;
YLAHERTTUALA, S ;
GURTNER, GC ;
SOCHER, SS ;
BUTLER, SW ;
PARTHASARATHY, S ;
CAREW, TE ;
STEINBERG, D ;
WITZTUM, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1372-1376
[35]   ANTISERA AND MONOCLONAL-ANTIBODIES SPECIFIC FOR EPITOPES GENERATED DURING OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J].
PALINSKI, W ;
YLAHERTTUALA, S ;
ROSENFELD, ME ;
BUTLER, SW ;
SOCHER, SA ;
PARTHASARATHY, S ;
CURTISS, LK ;
WITZTUM, JL .
ARTERIOSCLEROSIS, 1990, 10 (03) :325-335
[36]  
PARUMS DV, 1990, ARCH PATHOL LAB MED, V114, P383
[37]   ANTIBODIES AGAINST LIPOPROTEINS IN MAN OCCURRENCE AND BIOLOGICAL SIGNIFICANCE [J].
RIESEN, W ;
NOSEDA, G .
KLINISCHE WOCHENSCHRIFT, 1975, 53 (08) :353-361
[38]   AUTOANTIBODY AGAINST OXIDIZED LDL AND PROGRESSION OF CAROTID ATHEROSCLEROSIS [J].
SALONEN, JT ;
YLAHERTTUALA, S ;
YAMAMOTO, R ;
BUTLER, S ;
KORPELA, H ;
SALONEN, R ;
NYYSSONEN, K ;
PALINSKI, W ;
WITZTUM, JL .
LANCET, 1992, 339 (8798) :883-887
[39]   MODIFICATION OF LOW-DENSITY LIPOPROTEIN BY ENDOTHELIAL-CELLS INVOLVES LIPID-PEROXIDATION AND DEGRADATION OF LOW-DENSITY LIPOPROTEIN PHOSPHOLIPIDS [J].
STEINBRECHER, UP ;
PARTHASARATHY, S ;
LEAKE, DS ;
WITZTUM, JL ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (12) :3883-3887
[40]   FREE AND COMPLEXED ANTI-LIPOPROTEIN ANTIBODIES IN VASCULAR DISEASES [J].
SZONDY, E ;
HORVATH, M ;
MEZEY, Z ;
SZEKELY, J ;
LENGYEL, E ;
FUST, G ;
GERO, S .
ATHEROSCLEROSIS, 1983, 49 (01) :69-77